Not Tagged
Not Tagged
['mmsm']
the majority of patients are at standard risk! will need in the future to focus on trials only for high risk in ndmm with primary endpoint (os) if we are going to continue to add 4 or in some cases 5 drugs as induction therapy #mmsm #asco22
Associate Professor,Plasma Cell disorder program Director, Division of HMCT/University of Kansas Medical Center, no COI, #USMIRC Founder, #mmsm @KUMedCenter